{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:20:23Z","timestamp":1791091223521,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hamburger Krebsgesellschaft e.V. Mildred Scheel Cancer Career Center Hamburg"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271-TRR 205"],"award-info":[{"award-number":["314061271-TRR 205"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RI2616-106"],"award-info":[{"award-number":["RI2616-106"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["416054672"],"award-info":[{"award-number":["416054672"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006146","name":"F\u00f6rdergemeinschaft Kinderkrebs-Zentrum Hamburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010124","name":"Erich und Gertrud Roggenbuck-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010124","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Corticotroph pituitary neuroendocrine tumours (PitNETs)\/adenomas are heterogeneous sellar neoplasms. Currently established histopathological classification approaches are often considered limited in fully capturing the clinical and biological complexity of these tumours. Thus far, a molecular-based classification has not been established in corticotroph PitNETs. We compile molecular data of 270 corticotroph PitNETs (111 internal, 159 external), encompassing epigenome, transcriptome, and proteome profiles. Comprehensive integrative analyses are performed to identify, validate and characterise definitive molecular subgroups. Corticotroph PitNETs separate into four robust and clinicopathologically distinct molecular subgroups, which are broadly distinguishable by microscopy using SSTR1, GATA3 and SSTR5 immunohistochemistry. An integrated stratification model incorporating these molecular subgroups demonstrates significant prognostic utility. Our findings support the establishment of a refined molecular-based corticotroph PitNET classification, the full clinical value of which will require validation in prospective studies. To facilitate future research, we provide an easy-to-use epigenomic classifier for corticotroph PitNETs.<\/jats:p>","DOI":"10.1038\/s41467-026-76292-y","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:35:39Z","timestamp":1785857739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multi-omics integration unravels four molecular subgroups of corticotroph pituitary neuroendocrine tumours with distinct clinicopathological features"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9769-7080","authenticated-orcid":false,"given":"Matthias","family":"Dottermusch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Ryba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5828-6637","authenticated-orcid":false,"given":"Antonia","family":"Gocke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temor","family":"Rafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Soltwedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasja","family":"Lempertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4464-0427","authenticated-orcid":false,"given":"Linus","family":"Haberbosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2555-0602","authenticated-orcid":false,"given":"Luis Gustavo","family":"Perez-Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7378-4374","authenticated-orcid":false,"given":"Marily","family":"Theodoropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin","family":"Uksul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich J.","family":"Knappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonille","family":"Schweizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Saeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6080-0198","authenticated-orcid":false,"given":"Jakob","family":"Matschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Bujko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8731-1121","authenticated-orcid":false,"given":"Ulrich","family":"Sch\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7720-8817","authenticated-orcid":false,"given":"Markus","family":"Glatzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Flitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1321-6930","authenticated-orcid":false,"given":"Franz L.","family":"Ricklefs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1162-8771","authenticated-orcid":false,"given":"Julia E.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"76292_CR1","unstructured":"WHO Classification of Tumours Editorial Board. Endocrine and neuroendocrine tumours. Lyon (France): International Agency for Research on Cancer; 2022. WHO classification of tumours series, 5th ed.; vol. 8 (WHO, 2022)."},{"key":"76292_CR2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu, M. et al. Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. lancet Diab Endocrinol. 9, 847\u2013875 (2021).","journal-title":"lancet Diab Endocrinol."},{"key":"76292_CR3","doi-asserted-by":"publisher","first-page":"e13169","DOI":"10.1111\/jne.13169","volume":"34","author":"H Lasolle","year":"2022","unstructured":"Lasolle, H., Vasiljevic, A., Jouanneau, E., Ilie, M. D. & Raverot, G. Aggressive corticotroph tumors and carcinomas. J. Neuroendocrinol. 34, e13169 (2022).","journal-title":"J. Neuroendocrinol."},{"key":"76292_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1530\/EJE-22-0440","volume":"187","author":"P Burman","year":"2022","unstructured":"Burman, P. et al. Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients. Eur. J. Endocrinol. 187, 593\u2013605 (2022).","journal-title":"Eur. J. Endocrinol."},{"key":"76292_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa, S. L., Mete, O., Perry, A. & Osamura, R. Y. Overview of the 2022 WHO Classification of Pituitary Tumors. Endocr. Pathol. 33, 6\u201326 (2022).","journal-title":"Endocr. Pathol."},{"key":"76292_CR6","unstructured":"WHO Classification of Tumours Editorial Board. Central nervous system tumours. Lyon (France): International Agency for Research on Cancer; 2021. (WHO classification of tumours series, 5th ed.; vol. 6) (WHO, 2021)."},{"key":"76292_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.24875\/RIC.22000184","volume":"74","author":"LC Hern\u00e1ndez-Ram\u00edrez","year":"2022","unstructured":"Hern\u00e1ndez-Ram\u00edrez, L. C. & Hern\u00e1ndez-Ram\u00edrez, L. C. Determinants of clinical behavior and prognosis in Cushing\u2019s Disease: a quest for useful biomarkers. Rev. Investig. Cl\u00ednica 74, 244\u2013257 (2022).","journal-title":"Rev. Investig. Cl\u00ednica"},{"key":"76292_CR8","doi-asserted-by":"crossref","unstructured":"Villa, C., Baussart, B., Assi\u00e9, G., Raverot, G. & Roncaroli, F. The World Health Organization classifications of pituitary neuroendocrine tumours: a clinico-pathological appraisal. Endocr. Relat. Cancer 30, 230021 (2023).","DOI":"10.1530\/ERC-23-0021"},{"key":"76292_CR9","first-page":"2","volume":"5","author":"WC Mcdonald","year":"2024","unstructured":"Mcdonald, W. C. Pituitary adenoma classification: tools to improve the current system. Free Neuropathol. 5, 2\u20132 (2024).","journal-title":"Free Neuropathol."},{"key":"76292_CR10","first-page":"1039","volume":"104","author":"A Fountas","year":"2018","unstructured":"Fountas, A. et al. Recurrence in silent corticotroph adenomas after primary treatment: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 104, 1039\u20131048 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"76292_CR11","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41379-018-0016-8","volume":"31","author":"O Mete","year":"2018","unstructured":"Mete, O., Cintosun, A., Pressman, I. & Asa, S. L. Epidemiology and biomarker profile of pituitary adenohypophysial tumors. Mod. Pathol. 31, 900\u2013909 (2018).","journal-title":"Mod. Pathol."},{"key":"76292_CR12","doi-asserted-by":"crossref","unstructured":"Rak, B., Maksymowicz, M., P\u0119kul, M. & Zieli\u0144ski, G. Clinical, biological, radiological pathological and immediate post-operative remission of sparsely and densely granulated corticotroph pituitary tumors: a retrospective study of a cohort of 277 patients with Cushing\u2019s Disease. Front. Endocrinol. 12, 672178 (2021).","DOI":"10.3389\/fendo.2021.672178"},{"key":"76292_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/cr.2015.20","volume":"25","author":"ZY Ma","year":"2015","unstructured":"Ma, Z. Y. et al. Recurrent gain-of-function USP8 mutations in Cushing\u2019s disease. Cell Res.25, 306\u2013317 (2015).","journal-title":"Cell Res."},{"key":"76292_CR14","doi-asserted-by":"crossref","unstructured":"Reincke, M. et al. Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease. Nat. Genet. 47, 31\u201338 (2015).","DOI":"10.1038\/ng.3166"},{"key":"76292_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1530\/EC-20-0035","volume":"9","author":"S Castellnou","year":"2020","unstructured":"Castellnou, S. et al. SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors. Endocr. Connect. 9, 243\u2013253 (2020).","journal-title":"Endocr. Connect."},{"key":"76292_CR16","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1093\/ejendo\/lvaf097","volume":"192","author":"LG Perez-Rivas","year":"2025","unstructured":"Perez-Rivas, L. G., Von Selzam, V., Sharma, P., Reincke, M. & Theodoropoulou, M. Prevalence and clinical associations of USP8 variants in corticotroph tumours: a systematic review and aggregate data meta-analysis of 2171 cases. Eur. J. Endocrinol. 192, S41\u2013S52 (2025).","journal-title":"Eur. J. Endocrinol."},{"key":"76292_CR17","doi-asserted-by":"crossref","unstructured":"Bujko, M. et al. USP8 mutations in corticotroph adenomas determine a distinct gene expression profile irrespective of functional tumour status. Eur. J. Endocrinol. 181, 615\u2013627 (2019).","DOI":"10.1530\/EJE-19-0194"},{"key":"76292_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm10030375","volume":"10","author":"M Bujko","year":"2021","unstructured":"Bujko, M. et al. Differential microRNA expression in USP8-mutated and wild-type corticotroph pituitary tumors reflect the difference in protein ubiquitination processes. J. Clin. Med. 10, 1\u201315 (2021).","journal-title":"J. Clin. Med."},{"key":"76292_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou, M. et al. Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 37, 123\u2013134.e5 (2020).","journal-title":"Cancer Cell"},{"key":"76292_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00401-020-02149-3","volume":"140","author":"FL Ricklefs","year":"2020","unstructured":"Ricklefs, F. L. et al. Genome-wide DNA methylation profiles distinguish silent from non-silent ACTH adenomas. Acta Neuropathol. 140, 95\u201397 (2020).","journal-title":"Acta Neuropathol."},{"key":"76292_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper, D. et al. DNA methylation-based classification of central nervous system tumours. Nature 555, 469\u2013474 (2018).","journal-title":"Nature"},{"key":"76292_CR22","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1158\/1078-0432.CCR-17-2206","volume":"24","author":"MP Salomon","year":"2018","unstructured":"Salomon, M. P. et al. The epigenomic landscape of pituitary adenomas reveals specific alterations and differentiates among acromegaly, Cushing\u2019s disease and endocrine-inactive subtypes. Clin. Cancer Res. 24, 4126\u20134136 (2018).","journal-title":"Clin. Cancer Res."},{"key":"76292_CR23","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/s41422-022-00736-5","volume":"32","author":"F Zhang","year":"2022","unstructured":"Zhang, F. et al. Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors. Cell Res. 32, 1047\u20131067 (2022).","journal-title":"Cell Res."},{"key":"76292_CR24","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1210\/clinem\/dgac703","volume":"108","author":"RMPDA Silva-J\u00fanior","year":"2023","unstructured":"Silva-J\u00fanior, R. M. P. D. A. et al. Integrating methylome and transcriptome signatures expands the molecular classification of the pituitary tumors. J. Clin. Endocrinol. Metab. 108, 1452\u20131463 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"76292_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ccell.2025.11.002","volume":"44","author":"M Sill","year":"2026","unstructured":"Sill, M. et al. Advancing CNS tumor diagnostics with expanded DNA methylation-based classification. Cancer Cell 44, 340\u2013354.e2 (2026).","journal-title":"Cancer Cell"},{"key":"76292_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1530\/EJE-15-0689","volume":"174","author":"K Hayashi","year":"2016","unstructured":"Hayashi, K. et al. The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing\u2019s disease. Eur. J. Endocrinol. 174, 213\u2013226 (2016).","journal-title":"Eur. J. Endocrinol."},{"key":"76292_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1530\/ERC-22-0088","volume":"29","author":"A Albani","year":"2022","unstructured":"Albani, A. et al. Improved pasireotide response in USP8 mutant corticotroph tumours in vitro. Endocr. Relat. Cancer 29, 503\u2013511 (2022).","journal-title":"Endocr. Relat. Cancer"},{"key":"76292_CR28","doi-asserted-by":"crossref","unstructured":"Belakhoua, S. et al. DNA methylation profiling of pituitary neuroendocrine tumors identifies distinct clinical and pathological subtypes based on epigenetic differentiation. Neuro. Oncol. 27, 2341\u20132354 (2025).","DOI":"10.1093\/neuonc\/noaf109"},{"key":"76292_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00401-024-02836-5","volume":"148","author":"J Jotanovic","year":"2024","unstructured":"Jotanovic, J. et al. Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors. Acta Neuropathol. 148, 68 (2024).","journal-title":"Acta Neuropathol."},{"key":"76292_CR30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.mce.2018.01.020","volume":"473","author":"P Kober","year":"2018","unstructured":"Kober, P. et al. DNA methylation profiling in nonfunctioning pituitary adenomas. Mol. Cell. Endocrinol. 473, 194\u2013204 (2018).","journal-title":"Mol. Cell. Endocrinol."},{"key":"76292_CR31","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1210\/jc.2018-02164","volume":"104","author":"C Tatsi","year":"2019","unstructured":"Tatsi, C. et al. Large genomic aberrations in corticotropinomas are associated with greater aggressiveness. J. Clin. Endocrinol. Metab. 104, 1792\u20131801 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"76292_CR32","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1210\/clinem\/dgaa853","volume":"106","author":"AV Uzilov","year":"2021","unstructured":"Uzilov, A. V. et al. USP8 and TP53 drivers are associated with CNV in a corticotroph adenoma cohort enriched for aggressive tumors. J. Clin. Endocrinol. Metab. 106, 826\u2013842 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"76292_CR33","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1507\/endocrj.K08E-186","volume":"56","author":"T Tateno","year":"2009","unstructured":"Tateno, T. et al. Differential expression of somatostatin and dopamine receptor subtype genes in adrenocorticotropin (ACTH)-secreting pituitary tumors and silent corticotroph adenomas. Endocr. J. 56, 579\u2013584 (2009).","journal-title":"Endocr. J."},{"key":"76292_CR34","doi-asserted-by":"publisher","first-page":"1763735","DOI":"10.1155\/2018\/1763735","volume":"2018","author":"F Behling","year":"2018","unstructured":"Behling, F. et al. High expression of somatostatin receptors 2A, 3, and 5 in corticotroph pituitary adenoma. Int. J. Endocrinol. 2018, 1763735 (2018).","journal-title":"Int. J. Endocrinol."},{"key":"76292_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00401-024-02686-1","volume":"147","author":"M Dottermusch","year":"2024","unstructured":"Dottermusch, M. et al. Pituitary neuroendocrine tumors with PIT1\/SF1 co-expression show distinct clinicopathological and molecular features. Acta Neuropathol. 147, 16 (2024).","journal-title":"Acta Neuropathol."},{"key":"76292_CR36","doi-asserted-by":"publisher","unstructured":"Asa, S. L., Mete, O., Riddle, N. D. & Perry, A. Multilineage pituitary neuroendocrine tumors (PitNETs) expressing PIT1 and SF1. Endocr. Pathol. https:\/\/doi.org\/10.1007\/S12022-023-09777-X (2023).","DOI":"10.1007\/S12022-023-09777-X"},{"key":"76292_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000533692","volume":"114","author":"P Kober","year":"2024","unstructured":"Kober, P. et al. DNA methylation pattern in somatotroph pituitary neuroendocrine tumors. Neuroendocrinology 114, 51\u201363 (2024).","journal-title":"Neuroendocrinology"},{"key":"76292_CR38","doi-asserted-by":"crossref","unstructured":"Asa, S. L., Faiman, G. H., Mohamed, A. & Mete, O. Multilineage pituitary neuroendocrine tumors expressing TPIT and SF1: a clinicopathological series of six tumors. Endocr. Pathol. 35, 349\u2013353 (2024).","DOI":"10.1007\/s12022-024-09841-0"},{"key":"76292_CR39","doi-asserted-by":"crossref","unstructured":"Rymuza, J. et al. Transcriptomic classification of pituitary neuroendocrine tumors causing acromegaly. Cells 11, 3846 (2022).","DOI":"10.3390\/cells11233846"},{"key":"76292_CR40","doi-asserted-by":"publisher","first-page":"e12870","DOI":"10.1111\/nan.12870","volume":"49","author":"M Dottermusch","year":"2023","unstructured":"Dottermusch, M., Sch\u00fcller, U., Hagel, C. & Saeger, W. Unveiling the identities of null cell tumours: Epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour\/adenoma classification. Neuropathol. Appl. Neurobiol. 49, e12870 (2023).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"76292_CR41","doi-asserted-by":"publisher","first-page":"1302667","DOI":"10.3389\/fendo.2024.1302667","volume":"15","author":"M P\u0119kul","year":"2024","unstructured":"P\u0119kul, M. et al. Relevance of mutations in protein deubiquitinases genes and TP53 in corticotroph pituitary tumors. Front. Endocrinol. 15, 1302667 (2024).","journal-title":"Front. Endocrinol."},{"key":"76292_CR42","doi-asserted-by":"crossref","unstructured":"Rafiq, T., Matschke, J., Flitsch, J. & Dottermusch, M. Three synchronous pituitary neuroendocrine tumors-epigenomics confirm an exceptional triple PitNET. Endocr. Pathol. 36, 19 (2025).","DOI":"10.1007\/s12022-025-09864-1"},{"key":"76292_CR43","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12020-021-02954-0","volume":"76","author":"P Sumislawski","year":"2022","unstructured":"Sumislawski, P. et al. ACTH-secreting pituitary carcinoma with TP53, NF1, ATRX and PTEN mutations case report and review of the literature. Endocrine 76, 228\u2013236 (2022).","journal-title":"Endocrine"},{"key":"76292_CR44","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. (R Core Team, 2024)."},{"key":"76292_CR45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/1467-9868.00293","volume":"63","author":"R Tibshirani","year":"2001","unstructured":"Tibshirani, R., Walther, G. & Hastie, T. Estimating the number of clusters in a data set via the gap statistic. J. R. Stat. Soc. Ser. B Stat. Methodol. 63, 411\u2013423 (2001).","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."},{"key":"76292_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinforma. 14, 1\u201315 (2013).","journal-title":"BMC Bioinforma."},{"key":"76292_CR47","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/neuonc\/noz109","volume":"21","author":"S Sbiera","year":"2019","unstructured":"Sbiera, S. et al. Driver mutations in USP8 wild-type Cushing\u2019s disease. Neuro. Oncol. 21, 1273\u20131283 (2019).","journal-title":"Neuro. Oncol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76292-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76292-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76292-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:57:43Z","timestamp":1785859063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76292-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76292"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76292-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7777"}}